AOD-9604 produces no IGF-1 elevation, potentially making it more appropriate for individuals with cancer history or elevated baseline cancer risk
Choosing the right path to fat loss AOD 9604 and CJC 1295 have different fat loss benefits
Findings suggest it may operate differently than growth hormone, particularly in relation to receptor interaction and lean body mass
For this compound, the most important COA items usually include compound name, salt form, CAS number, molecular formula, molecular weight, lot number, assay or purity result, analytical method, identity confirmation method, water content if tested, residual solvents if tested, storage recommendation, and retest or expiration information where provided
AOD-9604 offers a gentler approach with more selective fat targeting and fewer systemic effects, making it suitable for individuals who cannot tolerate GLP-1 agonists or prefer a more focused mechanism